(Q50267679)

28 February 2018

title

Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. (English)

1 reference

28 February 2018

author name string

Sheree Watson

1

1 reference

28 February 2018

Licia Pensabene

2

1 reference

28 February 2018

Paul Mitchell

3

1 reference

28 February 2018

Athos Bousvaros

4

1 reference

28 February 2018

publication date

18 August 2010

1 reference

28 February 2018

Inflammatory Bowel Diseases

published in

1 reference

28 February 2018

volume

17

1 reference

28 February 2018

issue

1

1 reference

28 February 2018

page(s)

22-29

1 reference

28 February 2018

Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy.

cites work

1 reference

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial

21 January 2018

1 reference

FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond

21 January 2018

1 reference

Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial

21 January 2018

1 reference

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

21 January 2018

1 reference

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

21 January 2018

1 reference

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

21 January 2018

1 reference

Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease

21 January 2018

1 reference

Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children

21 January 2018

1 reference

Infliximab efficacy in pediatric ulcerative colitis

21 January 2018

1 reference

Infliximab as a novel therapy for pediatric ulcerative colitis

21 January 2018

1 reference

Infliximab in pediatric ulcerative colitis: two-year follow-up

21 January 2018

1 reference

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

21 January 2018

1 reference

Current therapy of inflammatory bowel disease in children

21 January 2018

1 reference

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

21 January 2018

1 reference

The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents

21 January 2018

1 reference

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up

21 January 2018

1 reference

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

21 January 2018

1 reference

Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease

21 January 2018

1 reference

Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis

21 January 2018

1 reference

Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis

21 January 2018

1 reference

The use of ciclosporin in paediatric inflammatory bowel disease: an Italian experience

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.21418

1 reference

28 February 2018

1 reference

28 February 2018